Here you can find a collection of publications by ESCMID.

Go directly to:

• ESCMID publications
• Medical Guidelines
• EUCAST
• EITaF
• TAE
• Position Papers
• Publications from Study Groups
• Publications from recipients of Research Grants

• Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline: Executive SummaryDaley C L, Iaccarino J M, Jr, Lange C, et al. Clin. Infect. Dis. 2020 doi:10.1093/cid/ciaa241
  
  

EFISG

• Invasive Pulmonary Aspergillosis treatment duration in haematology patients in Europe: an EFISG, IDWP‐EBMT, EORTC‐IDG, SEIFEM survey
  Lanternier F, Seidel D, Pagano L, et al. Mycoses 2020. doi: 10.1111/myc.13056

EFWISG

• Food-to-Humans Bacterial Transmission.
  Antunes P, Novais C, Peixe L. Microbiol Spectr 2020;8(1). doi: 10.1128/microbiolspec.MTBP-0019-2016.

ESGAI

• A Europe-wide assessment of antibiotic resistance rates in Bacteroides and Parabacteroides isolates from intestinal microbiota of healthy subjects.
  Sóki J, Wybo I, Hajdú E, et al. Anaerobe 2020 doi: 10.1016/j.anaerobe.2020.102182.
• Antimicrobial susceptibility profiles of anaerobic bacteria, isolated from human clinical specimens, within different European and surrounding countries. A joint ESGAI study.
  Veloo ACM, Tokman HB, Jean-Pierre H, et al. Anaerobe 2020 doi: 10.1016/j.anaerobe.2019.102111.

ESGB

• Minimum information guideline for spectrophotometric and fluorometric methods to assess biofilm formation in microplates
  Allkjaa J, Bjarnsholt T, Coenye T, et al. Biofilm 2020. doi:10.1016/j.bioflm.2019.100010
• The future of biofilm research – Report on the ‘2019 Biofilm Bash’
  Coenye T, Kjellerup B, Stoodley P, et al. Biofilm 2020. doi:10.1016/j.bioflm.2019.100012.

ESGBIES

• Bloodstream infections - Standard and progress in pathogen diagnostics.
  Lamy B, Sundqvist M, Idelevich EA et al. Clin Microbiol Infect 2020 doi: 10.1016/j.cmi.2019.11.017.

ESGBOR

• Unconventional diagnostic tests for Lyme borreliosis: a systematic review.
  Raffetin A, Saunier A, Bouiller K, et al. Clin Microbiol Infect 2020 doi: 10.1016/j.cmi.2019.06.033.
• Rejection of the name Borreliella and all proposed species comb. nov. placed therein.
  Margos G, Castillo-Ramirez S, Cutler S, et al. Int J Syst Evol Microbiol 2020 doi: 10.1099/ijsem.0.004149.

ESGCD

• The emergence of Clostridium difficile ribotypes 027 and 176 with a predominance of the Clostridium difficile ribotype 001 recognized in Slovakia following the European standardized Clostridium difficile infection surveillance of 2016.
  Novakova E, Stefkovicova M, Kopilec MG, et al. Int J Infect Dis 2020 doi: 10.1016/j.ijid.2019.10.038.
• Five-year Pan-European, longitudinal surveillance of Clostridium difficile ribotype prevalence and antimicrobial resistance: the extended ClosER study.
  Freeman J, Vernon J, Pilling S, et al. Eur J Clin Microbiol Infect Dis 2020 doi: 10.1007/s10096-019-03708-7.

ESGIAI

• Lower success rate of débridement and implant retention in late acute versus early acute periprosthetic joint infection caused by Staphylococcus spp. results from a matched cohort study.
  Wouthuyzen-Bakker M, Sebillotte M, Huotari K, ESCMID Study Group for Implant-Associated Infections (ESGIAI), et al. Clin Orthop Relat Res 2020. doi: 10.1097/CORR.0000000000001171.
• Propionibacterium/Cutibacterium species-related positive samples, identification, clinical and resistance features: a 10-year survey in a French hospital.
  Broly M, Ruffier d'Epenoux L, Guillouzouic A, et al. Eur J Clin Microbiol Infect Dis 2020 doi: 10.1007/s10096-020-03852-5.

ESGIB

• Prediction of unfavorable outcomes in West Nile virus neuroinvasive infection - Result of a multinational ID-IRI study.
  Popescu CP, Florescu SA, Hasbun R, et al. J Clin Virol. 2020 doi: 10.1016/j.jcv.2019.104213.
• A Prospective Cohort Study to Identify Clinical, Biological and Imaging Features That Predict Etiology of Acute Encephalitis
  Le Maréchal  M, Mailles  A, Seigneurin  A et al. Clin Infect Dis 2020 doi: 10.1093/cid/ciaa598.
  
  

ESGIE

• Considerations for the optimal management of antibiotic therapy in elderly patients.
  Falcone M, Paul M, Tiseo G, et al. J Glob Antimicrob Resist 2020 doi: 10.1016/j.jgar.2020.02.022.

ESGITM

• Parasitic skin infections: neglected diseases or just challenging for diagnosis?
  Gardini G, Tomasoni LR, Castelli F. Curr Opin Infect Dis 2020. doi: 10.1097/QCO.0000000000000634.

ESGLI

• A real-time PCR for specific detection of the Legionella pneumophila serogroup 1 ST1 complex.
  Ginevra C, Chastang J, David S et al. Clin Microbiol Infect 2020 doi: 10.1016/j.cmi.2019.09.002.

ESGMAC

• Mycoplasma pneumoniae infections, 11 countries in Europe and Israel, 2011 to 2016.
  Beeton ML, Zhang XS, Uldum SA, et al. Euro Surveill 2020 doi: 10.2807/1560-7917.ES.2020.25.2.1900112.

ESGMD

• Core/whole genome multilocus sequence typing and core genome SNP-based typing of OXA-48-producing Klebsiella pneumoniae clinical isolates from Spain.
  Miro E, Rossen JWA, Chlebowicz MA, et al. Front Microbiol 2020 doi: 10.3389/fmicb.2019.02961.

ESGREV

• Current and Future Point-of-Care Tests for Emerging and New Respiratory Viruses and Future Perspectives

  Nelson PP, Rath  BA, Fragkou  PC et al Front Cell Infect Microbiol 2020 doi: 10.3389/fcimb.2020.00181
  
  

ESGS

• Niche specialization and spread of Staphylococcus capitis involved in neonatal sepsis.
  Wirth T, Bergot M, Rasigade JP, et al. Nat Microbiol 2020 doi: 10.1038/s41564-020-0676-2.

ESGVH

• Elimination of hepatitis C in Europe: can WHO targets be achieved?
  Maticic M, Lombardi A, Mondelli MU, et al. Clin Microbiol Infect 2020  doi: 10.1016/j.cmi.2020.01.014.

ESGBIES & ESGICH

• A clinical predictive model of multidrug resistance in neutropenic cancer patients with bloodstream infection due to Pseudomonas aeruginosa (IRONIC study).
  Gudiol C, Albasanz-Puig A, Laporte-Amargós J, et al. Antimicrob Agents Chemother 2020 pii: AAC.02494-19. doi: 10.1128/AAC.02494-19.

ESGMYC & ESGITM & EITaF

• Tools to implement the WHO End TB Strategy: Addressing common challenges in high and low endemic countries.
  Al Abri S, Kasaeva T, Migliori GB, et al. Int J Infect Dis. 2020 pii: S1201-9712(20)30100-4. doi: 10.1016/j.ijid.2020.02.042.

To top